» Articles » PMID: 21504949

Developmental Regulation of P-glycoprotein Activity Within Thymocytes Results in Increased Anti-HIV Protease Inhibitor Activity

Overview
Journal J Leukoc Biol
Date 2011 Apr 21
PMID 21504949
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The thymus harbors HIV-1 and supports its replication. Treatment with PI-containing ART restores thymic output of naïve T cells. This study demonstrates that CXCR4-using WT viruses are more sensitive to PI in fetal thymcocytes than mature T cells with average IC(50) values for two PIs, RTV and IDV, of 1.5 nM (RTV) and 4.4 nM (IDV) in thymocytes versus 309.4 nM (RTV) and 27.3 nM (IDV) in mature T cells. P-gp activity, as measured using Rh123 efflux and quantitation of P-gp mRNA, increased with thymocyte maturation into CD4 and CD8 lineage T cells. P-gp activity is developmentally regulated in the thymus. Thymocytes developed increased levels of P-gp activity as maturation from DP to SP CD4 or CD8 T cells occurred, although CD4 T cells acquired activity more rapidly. Reduced P-gp activity in thymocytes is one mechanism for effectiveness of PI therapy in suppressing viral replication in the thymus and in reconstitution of naïve T cells, particularly among children receiving PI-containing ART.

Citing Articles

Pharmacology of HIV Cure: Site of Action.

Devanathan A, Cottrell M Clin Pharmacol Ther. 2021; 109(4):841-855.

PMID: 33540481 PMC: 8284849. DOI: 10.1002/cpt.2187.


P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.

Minuesa G, Arimany-Nardi C, Erkizia I, Cedeno S, Molto J, Clotet B J Antimicrob Chemother. 2016; 71(10):2782-92.

PMID: 27334660 PMC: 5031918. DOI: 10.1093/jac/dkw215.


Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Hu M, Patel S, Zhou T, Rohan L J Control Release. 2015; 219:681-696.

PMID: 26278511 PMC: 4656065. DOI: 10.1016/j.jconrel.2015.08.018.


Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

Hong S, Banks W Brain Behav Immun. 2014; 45:1-12.

PMID: 25449672 PMC: 4342286. DOI: 10.1016/j.bbi.2014.10.008.


P-glycoprotein and drug resistance in systemic autoimmune diseases.

Picchianti-Diamanti A, Rosado M, Scarsella M, Lagana B, DAmelio R Int J Mol Sci. 2014; 15(3):4965-76.

PMID: 24658440 PMC: 3975434. DOI: 10.3390/ijms15034965.

References
1.
Douek D, McFarland R, KEISER P, Gage E, Massey J, Haynes B . Changes in thymic function with age and during the treatment of HIV infection. Nature. 1999; 396(6712):690-5. DOI: 10.1038/25374. View

2.
Res P, Blom B, Hori T, Weijer K, Spits H . Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development. J Exp Med. 1997; 185(1):141-51. PMC: 2196108. DOI: 10.1084/jem.185.1.141. View

3.
Brooks D, Kitchen S, Kitchen C, Zack J . Generation of HIV latency during thymopoiesis. Nat Med. 2001; 7(4):459-64. DOI: 10.1038/86531. View

4.
Drewe J, Gutmann H, Fricker G, Torok M, Beglinger C, Huwyler J . HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol. 2001; 57(10):1147-52. DOI: 10.1016/s0006-2952(99)00026-x. View

5.
Lee C, Ramachandra M, Jeang K, Martin M, Pastan I, Gottesman M . Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter. FASEB J. 2000; 14(3):516-22. DOI: 10.1096/fasebj.14.3.516. View